SynGenis announced a partnership with SpeeDx Pty Ltd., a developer of innovative molecular diagnostic solutions. The partnership will support the expansion of SynGenis to provide reliable, high quality large-scale oligonucleotides and bolster internal capacity of SpeeDx to support large-scale increases in manufacturing while developing and expanding sovereign capacity of important raw materials used in molecular diagnostics.
Read the full press release